Acute effects of ozone on mortality from the "Air Pollution and Health: A European Approach" project

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 10, 2004, Pages 1080-1087

  Gryparis, Alexandros ^b   Forsberg, Bertil ^b   Katsouyanni, Klea ^a   Analitis, Antonis ^b   Touloumi, Giota ^b   Schwartz, Joel ^b   Samoli, Evangelia ^b   Medina, Sylvia ^b   Anderson, H Ross ^b   Niciu, Emilia Maria ^b   Wichmann, H Erich ^b   Kriz, Bohumir ^b   Kosnik, Mitja ^b   Skorkovsky, Jiri ^b   Vonk, Judith M ^b   Dörtbudak, Zeynep ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

Cardiovascular mortality; Respiratory mortality; Time series

Indexed keywords

OZONE; SULFUR DIOXIDE;

AIR POLLUTION; AMBIENT AIR; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENVIRONMENTAL HEALTH; EUROPE; HUMAN; INFORMATION PROCESSING; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASE; SEASON;

AIR POLLUTANTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CONFIDENCE INTERVALS; ENVIRONMENTAL MONITORING; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; ODDS RATIO; OZONE; REGISTRIES; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; URBAN POPULATION;

EID: 8444235628     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200403-333OC     Document Type: Article

References (52)

1. Dockery DW, Pope CA III. Acute respiratory effects of particulate air pollution. Annu Rev Public Health 1994;15:107-132.
2. Samet JM, Zeger SL, Dominici F, Curriero F, Coursac I, Dockery DW, Schwartz J, Zanobetti A. The National Morbidity, Mortality and Air Pollution Study (NMMAPS), part II: results: Health Effects Institute Research Report Number 94. Boston: Health Effects Institute; 2000.
3. Katsouyanni K, Touloumi G, Samoli E, Gryparis A, Le Tertre A, Monopolis Y, Rossi G, Zmirou D, Ballester F, Boumghar A, et al. Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology 2001;12:521-531.
4. Kinney PL, Ware JH, Spengler JD. A critical evaluation of acute ozone epidemiology results. Arch Environ Health 1988;43:168-173.
5. Kinney PL, Ozkaynak H. Associations of daily mortality and air pollution in Los Angeles County. Environ Res 1991;54:99-120.
6. Thurston GD, Ito K, Kinney PL, Lippmann M. A multiyear study of air pollution and respiratory hospital admissions in three New York State metropolitan areas results for 1988 and 1989 summers. J Expo Anal Environ Epidemiol 1992;2:429-450.
7. Romieu I, Lugo MC, Velasco SR, Sanchez S, Meneses F, Hernandez M. Air pollution and school absenteeism among children in Mexico City. Am J Epidemiol 1992;136:1524-1531.
8. Ostro BD, Lipsett MJ, Mann JK, Krupnick A, Harrington W. Air pollution and respiratory morbidity among adults in southern California. Am J Epidemiol 1993;137:691-700.
9. 1 data from six summer camp studies: mean effect of ozone on response heterogeneity [abstract]. Am Rev Respir Dis 1993;147:A636.
10. Lippmann M. Health effects of tropospheric ozone: review of recent research findings and their implications to ambient air quality standards. J Expo Anal Environ Epidemiol 1993;3:103-129.
11. Frischer TM, Kuehr J, Pullwitt A, Meinert R, Forster J, Studnicka M, Koren H. Ambient ozone causes upper airways inflammation in children. Am Rev Respir Dis 1993;148:961-964.
12. US Environmental Protection Agency (EPA). Air quality criteria for ozone and related photochemical oxidants. EPA/600/AP-93/004a-c. Washington, DC: U.S. Office of Research and Development, EPA; 1993.
13. Burnett RT, Dales RE, Raizenne ME, Krewski D, Summers PW, Roberts GR, Raad-Young M, Dann T, Brook J. Effects of low ambient levels of ozone and sulphates on the frequency of respiratory admissions to Ontario hospitals. Environ Res 1994;65:172-194.
14. Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, Koren HS. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 1991;4:72-81.
15. Balmes JR, Chen LL, Scannell C, Tager I, Christian D, Hearne PQ, Kelly T, Aris RM. Ozone-induced decrements in FEV, and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 1996;153:904-909.
16. Foster WM, Stetkiewicz PT. Regional clearance of solute from the respiratory epithelia: 18-20 hr postexposure to ozone. J Appl Physiol 1996; 81:1143-1149.
17. Foster WM, Costa DL, Langenback EG. Ozone exposure alters tracheobronchial mucociliary function in humans. J Appl Physiol 1987;63:996-1002.
18. Spannhake EW, Reddy SP, Jacoby DB, Yu XY, Saatian B, Tian J. Synergism between rhinovirus infection and oxidant pollutant exposure enhances airway epithelial cell cytokine production. Environ Health Perspect 2002;110:665-670.
19. Farrell BP, Kerr HD, Kulle TJ, Sauder LR, Young JL. Adaptation in human subjects to the effects of inhaled ozone after repeated exposures. Am Rev Respir Dis 1979;79:725-730.
20. Devlin RB, Folinsbee LJ, Biscardi F, Hatch G, Becker S, Madden MC, Robbins M, Koren HS. Inflammation and cell damage induced by repeated exposure of humans to ozone. Inhal Toxicol 1997;9:211-235.
21. Folinsbee LJ, McDonnell WF, Horstman DH. Pulmonary function and symptom responses after 6.6 hour exposure to 0.12 ppm ozone with moderate exercise. J Air Pollut Control Assoc 1988;38:28-35.
22. Jorres RA, Holtz O, Zachgo W, Timm P, Koschyk S, Muller B, Grimminger F, Seeger W, Kelly FJ, Dunster C, et al. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med 2000;161:1855-1861.
23. Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med 2000;21:1-48.
24. Katsouyanni K, Schwartz J, Spix C, Touloumi G, Zmirou D, Zanobetti A, Wojtyniak B, Vonk J, Tobias A, Ponka A, et al. Short-term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health 1996;50:S12-S18.
25. Katsouyanni K, Touloumi G, Spix C, Schwartz J, Balducci F, Medina S, Rossi G, Wojtyniak B, Sunyer J, Bacharova L, et al. Short-term effects of ambient sulphur dioxide and particulate matter on mortality in 12 European cities: results from time series data from the APHEA project. Br Med J 1997;314:1658-1663.
26. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 US cities 1987-1994. N Engl J Med 2000;343:1742-1749.
27. Dockery D, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An association between air pollution and mortality in six US cities. N Engl J Med 1993;329:1753-1759.
28. US Environmental Protection Agency (EPA). Review of the National Ambient Air Quality Standards for Particulate Matter: policy assessment of scientific and technical information. QAQPS Staff Paper. EPA-45R-96-013. Research Triangle Park, NCC: U.S. Government Printing Office, Office of Air Quality Planning and Standards, EPA; 1996.
29. Commission of the European Communities. Council Directive 1999/30/ EC relating to limit values for sulphur dioxide, oxides of nitrogen, particulate matter and lead in ambient air. Official J Eur Communities 1999;L163:41-60.
30. Touloumi G, Katsouyanni K, Zmirou D, Schwartz J, Spix C, Ponce de Leon A, Tobias A, Quenel P, Rabczenko D, Bacharova L, et al. Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Am J Epidemiol 1997;146:177-185.
31. Gryparis A, Samoli E, Touloumi G, Forsberg B. Katsouyanni K on behalf of the APHEA2 group: ozone effects on total mortality: results from the APHEA2 project [abstract]. Epidemiology 2001;12:S71.
32. Hastie T, Tibshirani R. Generalized additive models. London: Chapman and Hall; 1990.
33. Touloumi G, Atkinson R, Le Tertre A, Samoli E, Schwartz J, Schindler C, Vonk JM, Rossi G. Saez M, Rabczenko D, et al. Analysis of health outcome time series data in epidemiological studies. Environmetrics 2003;14:1-17.
34. Cleveland WS, Devlin SJ. Robust locally-weighted regression and smoothing scatterplots. J Am Stat Assoc 1988;74:829-836.
35. Thurston GD, Ito K. Epidemiological studies of ozone exposure effects. In: Holgate ST, Samet JM, Koren HS, Maynard RL, editors. Air pollution and health. San Diego, CA: Academic Press; 1999. p. 485-510.
36. Schwartz J. The distributed lag between air pollution and daily deaths. Epidemiology 2000;11:320-326.
37. Brumback BA, Ryan LM, Schwartz JD, Neas LM, Stark PC, Burge HA. Transitional regression models, with application to environmental time series. J Am Stat Assoc 2000;95:16-21.
38. Berkey CS, Hoaglin DC, Mossteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med 1995;14:395-411.
39. Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA. Meta-analysis of multiple outcomes by regression with random effects. Stat Med 1998;17:2537-2550.
40. Schwartz J, Zanobetti A. Using meta-smoothing to estimate dose-response trends across multiple studies, with application to air pollution and daily death. Epidemiology 2000;11:666-672.
41. S-PLUS 2000, Professional Release 3. Seattle, WA: Math Soft; 2000.
42. Dominici F, McDermott A, Zeger SL, Samet JM. On the use of generalized additive models in time-series studies of air pollution and health. Am J Epidemiol 2002;156:193-203.
43. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
44. Ramsay TO, Burnett R, Krewski D. The effect of concurvity in generalized additive models linking mortality to ambient particulate matter. Epidemiology 2003;14:18-23.
45. Special Report HEI. Revised analyses of time-series studies of air pollution and health. Boston: Health Effects Institute; 2003.
46. Daniels M, Dominici F, Zeger SL. Underestimation of standard errors in multi site time series studies. Epidemiology 2004;15:57-62.
47. Air Quality Guidelines for Europe. WHO Regional Publications, European Series, No 91. Copenhagen: World Health Organisation; 2000.
48. Levy JI, Carrothers TJ, Tuomisto JT, Hammitt JK, Evans JS. Assessing the public health benefits of reduced ozone concentrations. Environ Health Perspect 2001;109:1215-1226.
49. Watkinson WP, Campen MJ, Nolan JP, Costa DL. Cardiovascular and systemic responses to inhaled pollutants in rodents: effects of ozone and particulate matter. Environ Health Perspect 2001;109:539-546.
50. De Leon SF, Thurston GD, Kazuhito I. Contribution of respiratory disease to non-respiratory mortality associations with air pollution. Am J Respir Crit Care Med 2003;167:1117-1123.
51. Air Quality Guidelines for Europe. WHO Regional Publications, European Series, No 23. Copenhagen: World Health Organisation; 1987.
52. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Tellez-Rojo MM, Moreno-Macias H, Reyes-Ruiz NI, Del Rio-Navarro BE, Ruiz-Navarro MX, Hatch G, Slade R, et al. Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am J Respir Crit Care Med 2002;166:703-709.